市場調査レポート

商品コード

1304975

がん登録ソフトウェア市場：タイプ別、データベースタイプ別、機能別、展開別、エンドユーザー別-2023-2030年の世界予測

Cancer Registry Software Market by Type, Database Type, Functionality, Deployment, End User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

出版日: 2023年06月12日 | 発行: 360iResearch

| ページ情報: 英文 187 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF, Excel & Online Access - 1 Year (Single User License)

USD 4,749 749,867円

レポートPDF及びExcelを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Up to 5 User License)

USD 5,749 907,767円

レポートPDF及びExcelを5名まで共有ご利用頂けるライセンスです。ご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Site License)

USD 6,749 1,065,667円

レポートPDF及びExcelを同一事業所（所在地）内のすべての方でご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Enterprise User License)

USD 8,749 1,381,467円

レポートPDF及びExcelを同一企業の全世界の方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.90円

ご注意事項 :

本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

がん登録ソフトウェアの世界市場は、2023年にCAGR 11.96%で8,762万米ドルが予測され、2030年には1億9,347万米ドルに達するという驚異的な成長を遂げると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界のがん登録ソフトウェア市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.がん登録ソフトウェアの世界市場規模および予測は？

2.予測期間中、世界のがん登録ソフトウェア市場を形成するCOVID-19の阻害要因と影響は？

3.がん登録ソフトウェアの世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.がん登録ソフトウェアの世界市場における競争戦略は？

5.がん登録ソフトウェアの世界市場における技術動向と規制の枠組みは？

6.がん登録ソフトウェアの世界市場における主要ベンダーの市場シェアは？

7.がん登録ソフトウェアの世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

市場力学
- 促進要因
  - 世界中でがん罹患率が急増
  - 電子医療記録の普及が進む
  - クラウドベースのがん患者登録ソフトウェアソリューションに対する需要の増加
- 抑制要因
  - エンドユーザーの間でがん登録ソフトウェアに関する認識が不足している
- 機会
  - がん登録ソフトウェアの開発に向けた政府の取り組みの急増
  - がん登録ソフトウェアソリューションの技術開発
- 課題
  - データのセキュリティとプライバシーに関する懸念
市場動向
COVID-19の累積的な影響
ロシア・ウクライナ紛争の累積的影響
高インフレの累積的影響
ポーターのファイブフォース分析
バリューチェーンとクリティカルパス分析
規制の枠組み
顧客のカスタマイズ

第6章がん登録ソフトウェア市場：タイプ別

統合ソフトウェア
スタンドアロンソフトウェア

第7章がん登録ソフトウェア市場データベースの種類別

商用データベース
公開データベース

第8章がん登録ソフトウェア市場機能別

がんの報告
医学調査と臨床研究
患者ケア管理
製品の成果評価

第9章がん登録ソフトウェア市場：展開別

オンクラウド
オンプレミス

第10章がん登録ソフトウェア市場：エンドユーザー別

政府機関およびサードパーティ管理者
病院と医療行為
製薬、バイオテクノロジー、医療機器企業
民間の支払者
研究センター

第11章南北アメリカのがん登録ソフトウェア市場

アルゼンチン
ブラジル
カナダ
メキシコ
米国

第12章アジア太平洋地域のがん登録ソフトウェア市場

オーストラリア
中国
インド
インドネシア
日本
マレーシア
フィリピン
シンガポール
韓国
台湾
タイ
ベトナム

第13章欧州・中東・アフリカのがん登録ソフトウェア市場

デンマーク
エジプト
フィンランド
フランス
ドイツ
イスラエル
イタリア
オランダ
ナイジェリア
ノルウェー
ポーランド
カタール
ロシア
サウジアラビア
南アフリカ
スペイン
スウェーデン
スイス
トルコ
アラブ首長国連邦
英国

第14章競合情勢

FPNVポジショニングマトリクス
市場シェア分析：主要企業別
競合シナリオ分析：主要企業別

第15章掲載企業一覧

第16章付録

ディスカッションガイド
ライセンスと価格について

図表

LIST OF FIGURES

FIGURE 1. CANCER REGISTRY SOFTWARE MARKET RESEARCH PROCESS
FIGURE 2. CANCER REGISTRY SOFTWARE MARKET SIZE, 2022 VS 2030
FIGURE 3. CANCER REGISTRY SOFTWARE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. CANCER REGISTRY SOFTWARE MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
FIGURE 5. CANCER REGISTRY SOFTWARE MARKET SIZE, BY DATABASE TYPE, 2022 VS 2030 (%)
FIGURE 6. CANCER REGISTRY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2022 VS 2030 (%)
FIGURE 7. CANCER REGISTRY SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2022 VS 2030 (%)
FIGURE 8. CANCER REGISTRY SOFTWARE MARKET SIZE, BY END USER, 2022 VS 2030 (%)
FIGURE 9. CANCER REGISTRY SOFTWARE MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 10. CANCER REGISTRY SOFTWARE MARKET DYNAMICS
FIGURE 11. CANCER REGISTRY SOFTWARE MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 12. CANCER REGISTRY SOFTWARE MARKET SIZE, BY DATABASE TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. CANCER REGISTRY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 14. CANCER REGISTRY SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. CANCER REGISTRY SOFTWARE MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS CANCER REGISTRY SOFTWARE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CANCER REGISTRY SOFTWARE MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC CANCER REGISTRY SOFTWARE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CANCER REGISTRY SOFTWARE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 20. CANCER REGISTRY SOFTWARE MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 21. CANCER REGISTRY SOFTWARE MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

TABLE 1. CANCER REGISTRY SOFTWARE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. CANCER REGISTRY SOFTWARE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. CANCER REGISTRY SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 5. CANCER REGISTRY SOFTWARE MARKET SIZE, BY INTEGRATED SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 6. CANCER REGISTRY SOFTWARE MARKET SIZE, BY STANDALONE SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. CANCER REGISTRY SOFTWARE MARKET SIZE, BY DATABASE TYPE, 2018-2030 (USD MILLION)
TABLE 8. CANCER REGISTRY SOFTWARE MARKET SIZE, BY COMMERCIAL DATABASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. CANCER REGISTRY SOFTWARE MARKET SIZE, BY PUBLIC DATABASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. CANCER REGISTRY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 11. CANCER REGISTRY SOFTWARE MARKET SIZE, BY CANCER REPORTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. CANCER REGISTRY SOFTWARE MARKET SIZE, BY MEDICAL RESEARCH & CLINICAL STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. CANCER REGISTRY SOFTWARE MARKET SIZE, BY PATIENT CARE MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. CANCER REGISTRY SOFTWARE MARKET SIZE, BY PRODUCT OUTCOME EVALUATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. CANCER REGISTRY SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 16. CANCER REGISTRY SOFTWARE MARKET SIZE, BY ON-CLOUD, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. CANCER REGISTRY SOFTWARE MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. CANCER REGISTRY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 19. CANCER REGISTRY SOFTWARE MARKET SIZE, BY GOVERNMENT ORGANIZATIONS & THIRD-PARTY ADMINISTRATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. CANCER REGISTRY SOFTWARE MARKET SIZE, BY HOSPITALS & MEDICAL PRACTICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. CANCER REGISTRY SOFTWARE MARKET SIZE, BY PHARMACEUTICAL, BIOTECHNOLOGY & MEDICAL DEVICE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. CANCER REGISTRY SOFTWARE MARKET SIZE, BY PRIVATE PAYERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. CANCER REGISTRY SOFTWARE MARKET SIZE, BY RESEARCH CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS CANCER REGISTRY SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS CANCER REGISTRY SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS CANCER REGISTRY SOFTWARE MARKET SIZE, BY DATABASE TYPE, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS CANCER REGISTRY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS CANCER REGISTRY SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS CANCER REGISTRY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA CANCER REGISTRY SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA CANCER REGISTRY SOFTWARE MARKET SIZE, BY DATABASE TYPE, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA CANCER REGISTRY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA CANCER REGISTRY SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA CANCER REGISTRY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL CANCER REGISTRY SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL CANCER REGISTRY SOFTWARE MARKET SIZE, BY DATABASE TYPE, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL CANCER REGISTRY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL CANCER REGISTRY SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL CANCER REGISTRY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 40. CANADA CANCER REGISTRY SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 41. CANADA CANCER REGISTRY SOFTWARE MARKET SIZE, BY DATABASE TYPE, 2018-2030 (USD MILLION)
TABLE 42. CANADA CANCER REGISTRY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 43. CANADA CANCER REGISTRY SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 44. CANADA CANCER REGISTRY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 45. MEXICO CANCER REGISTRY SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 46. MEXICO CANCER REGISTRY SOFTWARE MARKET SIZE, BY DATABASE TYPE, 2018-2030 (USD MILLION)
TABLE 47. MEXICO CANCER REGISTRY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 48. MEXICO CANCER REGISTRY SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 49. MEXICO CANCER REGISTRY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES CANCER REGISTRY SOFTWARE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES CANCER REGISTRY SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES CANCER REGISTRY SOFTWARE MARKET SIZE, BY DATABASE TYPE, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES CANCER REGISTRY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES CANCER REGISTRY SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES CANCER REGISTRY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC CANCER REGISTRY SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC CANCER REGISTRY SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC CANCER REGISTRY SOFTWARE MARKET SIZE, BY DATABASE TYPE, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC CANCER REGISTRY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC CANCER REGISTRY SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC CANCER REGISTRY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 62. AUSTRALIA CANCER REGISTRY SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63. AUSTRALIA CANCER REGISTRY SOFTWARE MARKET SIZE, BY DATABASE TYPE, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA CANCER REGISTRY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA CANCER REGISTRY SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA CANCER REGISTRY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 67. CHINA CANCER REGISTRY SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 68. CHINA CANCER REGISTRY SOFTWARE MARKET SIZE, BY DATABASE TYPE, 2018-2030 (USD MILLION)
TABLE 69. CHINA CANCER REGISTRY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 70. CHINA CANCER REGISTRY SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 71. CHINA CANCER REGISTRY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. INDIA CANCER REGISTRY SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 73. INDIA CANCER REGISTRY SOFTWARE MARKET SIZE, BY DATABASE TYPE, 2018-2030 (USD MILLION)
TABLE 74. INDIA CANCER REGISTRY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 75. INDIA CANCER REGISTRY SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 76. INDIA CANCER REGISTRY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. INDONESIA CANCER REGISTRY SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 78. INDONESIA CANCER REGISTRY SOFTWARE MARKET SIZE, BY DATABASE TYPE, 2018-2030 (USD MILLION)
TABLE 79. INDONESIA CANCER REGISTRY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA CANCER REGISTRY SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA CANCER REGISTRY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 82. JAPAN CANCER REGISTRY SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 83. JAPAN CANCER REGISTRY SOFTWARE MARKET SIZE, BY DATABASE TYPE, 2018-2030 (USD MILLION)
TABLE 84. JAPAN CANCER REGISTRY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 85. JAPAN CANCER REGISTRY SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 86. JAPAN CANCER REGISTRY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. MALAYSIA CANCER REGISTRY SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. MALAYSIA CANCER REGISTRY SOFTWARE MARKET SIZE, BY DATABASE TYPE, 2018-2030 (USD MILLION)
TABLE 89. MALAYSIA CANCER REGISTRY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA CANCER REGISTRY SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA CANCER REGISTRY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. PHILIPPINES CANCER REGISTRY SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 93. PHILIPPINES CANCER REGISTRY SOFTWARE MARKET SIZE, BY DATABASE TYPE, 2018-2030 (USD MILLION)
TABLE 94. PHILIPPINES CANCER REGISTRY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES CANCER REGISTRY SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES CANCER REGISTRY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. SINGAPORE CANCER REGISTRY SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 98. SINGAPORE CANCER REGISTRY SOFTWARE MARKET SIZE, BY DATABASE TYPE, 2018-2030 (USD MILLION)
TABLE 99. SINGAPORE CANCER REGISTRY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE CANCER REGISTRY SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE CANCER REGISTRY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. SOUTH KOREA CANCER REGISTRY SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 103. SOUTH KOREA CANCER REGISTRY SOFTWARE MARKET SIZE, BY DATABASE TYPE, 2018-2030 (USD MILLION)
TABLE 104. SOUTH KOREA CANCER REGISTRY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA CANCER REGISTRY SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA CANCER REGISTRY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. TAIWAN CANCER REGISTRY SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 108. TAIWAN CANCER REGISTRY SOFTWARE MARKET SIZE, BY DATABASE TYPE, 2018-2030 (USD MILLION)
TABLE 109. TAIWAN CANCER REGISTRY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN CANCER REGISTRY SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN CANCER REGISTRY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. THAILAND CANCER REGISTRY SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 113. THAILAND CANCER REGISTRY SOFTWARE MARKET SIZE, BY DATABASE TYPE, 2018-2030 (USD MILLION)
TABLE 114. THAILAND CANCER REGISTRY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 115. THAILAND CANCER REGISTRY SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 116. THAILAND CANCER REGISTRY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. VIETNAM CANCER REGISTRY SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 118. VIETNAM CANCER REGISTRY SOFTWARE MARKET SIZE, BY DATABASE TYPE, 2018-2030 (USD MILLION)
TABLE 119. VIETNAM CANCER REGISTRY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM CANCER REGISTRY SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM CANCER REGISTRY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA CANCER REGISTRY SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA CANCER REGISTRY SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA CANCER REGISTRY SOFTWARE MARKET SIZE, BY DATABASE TYPE, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA CANCER REGISTRY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA CANCER REGISTRY SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA CANCER REGISTRY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 128. DENMARK CANCER REGISTRY SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 129. DENMARK CANCER REGISTRY SOFTWARE MARKET SIZE, BY DATABASE TYPE, 2018-2030 (USD MILLION)
TABLE 130. DENMARK CANCER REGISTRY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 131. DENMARK CANCER REGISTRY SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 132. DENMARK CANCER REGISTRY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. EGYPT CANCER REGISTRY SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 134. EGYPT CANCER REGISTRY SOFTWARE MARKET SIZE, BY DATABASE TYPE, 2018-2030 (USD MILLION)
TABLE 135. EGYPT CANCER REGISTRY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 136. EGYPT CANCER REGISTRY SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 137. EGYPT CANCER REGISTRY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. FINLAND CANCER REGISTRY SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 139. FINLAND CANCER REGISTRY SOFTWARE MARKET SIZE, BY DATABASE TYPE, 2018-2030 (USD MILLION)
TABLE 140. FINLAND CANCER REGISTRY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 141. FINLAND CANCER REGISTRY SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 142. FINLAND CANCER REGISTRY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. FRANCE CANCER REGISTRY SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 144. FRANCE CANCER REGISTRY SOFTWARE MARKET SIZE, BY DATABASE TYPE, 2018-2030 (USD MILLION)
TABLE 145. FRANCE CANCER REGISTRY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 146. FRANCE CANCER REGISTRY SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 147. FRANCE CANCER REGISTRY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 148. GERMANY CANCER REGISTRY SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 149. GERMANY CANCER REGISTRY SOFTWARE MARKET SIZE, BY DATABASE TYPE, 2018-2030 (USD MILLION)
TABLE 150. GERMANY CANCER REGISTRY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 151. GERMANY CANCER REGISTRY SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 152. GERMANY CANCER REGISTRY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. ISRAEL CANCER REGISTRY SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 154. ISRAEL CANCER REGISTRY SOFTWARE MARKET SIZE, BY DATABASE TYPE, 2018-2030 (USD MILLION)
TABLE 155. ISRAEL CANCER REGISTRY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL CANCER REGISTRY SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL CANCER REGISTRY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. ITALY CANCER REGISTRY SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 159. ITALY CANCER REGISTRY SOFTWARE MARKET SIZE, BY DATABASE TYPE, 2018-2030 (USD MILLION)
TABLE 160. ITALY CANCER REGISTRY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 161. ITALY CANCER REGISTRY SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 162. ITALY CANCER REGISTRY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. NETHERLANDS CANCER REGISTRY SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 164. NETHERLANDS CANCER REGISTRY SOFTWARE MARKET SIZE, BY DATABASE TYPE, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS CANCER REGISTRY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS CANCER REGISTRY SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS CANCER REGISTRY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 168. NIGERIA CANCER REGISTRY SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 169. NIGERIA CANCER REGISTRY SOFTWARE MARKET SIZE, BY DATABASE TYPE, 2018-2030 (USD MILLION)
TABLE 170. NIGERIA CANCER REGISTRY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA CANCER REGISTRY SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA CANCER REGISTRY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. NORWAY CANCER REGISTRY SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 174. NORWAY CANCER REGISTRY SOFTWARE MARKET SIZE, BY DATABASE TYPE, 2018-2030 (USD MILLION)
TABLE 175. NORWAY CANCER REGISTRY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 176. NORWAY CANCER REGISTRY SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 177. NORWAY CANCER REGISTRY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 178. POLAND CANCER REGISTRY SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 179. POLAND CANCER REGISTRY SOFTWARE MARKET SIZE, BY DATABASE TYPE, 2018-2030 (USD MILLION)
TABLE 180. POLAND CANCER REGISTRY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 181. POLAND CANCER REGISTRY SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 182. POLAND CANCER REGISTRY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 183. QATAR CANCER REGISTRY SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 184. QATAR CANCER REGISTRY SOFTWARE MARKET SIZE, BY DATABASE TYPE, 2018-2030 (USD MILLION)
TABLE 185. QATAR CANCER REGISTRY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 186. QATAR CANCER REGISTRY SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 187. QATAR CANCER REGISTRY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 188. RUSSIA CANCER REGISTRY SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA CANCER REGISTRY SOFTWARE MARKET SIZE, BY DATABASE TYPE, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA CANCER REGISTRY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA CANCER REGISTRY SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA CANCER REGISTRY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA CANCER REGISTRY SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA CANCER REGISTRY SOFTWARE MARKET SIZE, BY DATABASE TYPE, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA CANCER REGISTRY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA CANCER REGISTRY SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA CANCER REGISTRY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. SOUTH AFRICA CANCER REGISTRY SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA CANCER REGISTRY SOFTWARE MARKET SIZE, BY DATABASE TYPE, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA CANCER REGISTRY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA CANCER REGISTRY SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA CANCER REGISTRY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 203. SPAIN CANCER REGISTRY SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 204. SPAIN CANCER REGISTRY SOFTWARE MARKET SIZE, BY DATABASE TYPE, 2018-2030 (USD MILLION)
TABLE 205. SPAIN CANCER REGISTRY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 206. SPAIN CANCER REGISTRY SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 207. SPAIN CANCER REGISTRY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 208. SWEDEN CANCER REGISTRY SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN CANCER REGISTRY SOFTWARE MARKET SIZE, BY DATABASE TYPE, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN CANCER REGISTRY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN CANCER REGISTRY SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN CANCER REGISTRY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 213. SWITZERLAND CANCER REGISTRY SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 214. SWITZERLAND CANCER REGISTRY SOFTWARE MARKET SIZE, BY DATABASE TYPE, 2018-2030 (USD MILLION)
TABLE 215. SWITZERLAND CANCER REGISTRY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND CANCER REGISTRY SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND CANCER REGISTRY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 218. TURKEY CANCER REGISTRY SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 219. TURKEY CANCER REGISTRY SOFTWARE MARKET SIZE, BY DATABASE TYPE, 2018-2030 (USD MILLION)
TABLE 220. TURKEY CANCER REGISTRY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 221. TURKEY CANCER REGISTRY SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 222. TURKEY CANCER REGISTRY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES CANCER REGISTRY SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES CANCER REGISTRY SOFTWARE MARKET SIZE, BY DATABASE TYPE, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES CANCER REGISTRY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES CANCER REGISTRY SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES CANCER REGISTRY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. UNITED KINGDOM CANCER REGISTRY SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM CANCER REGISTRY SOFTWARE MARKET SIZE, BY DATABASE TYPE, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM CANCER REGISTRY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM CANCER REGISTRY SOFTWARE MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM CANCER REGISTRY SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. CANCER REGISTRY SOFTWARE MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 234. CANCER REGISTRY SOFTWARE MARKET SHARE, BY KEY PLAYER, 2022
TABLE 235. CANCER REGISTRY SOFTWARE MARKET LICENSE & PRICING

Product Code: MRR-034230D3E2B9

The Global Cancer Registry Software Market is forecasted to grow significantly, with a projected USD 87.62 million in 2023 at a CAGR of 11.96% and expected to reach a staggering USD 193.47 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Cancer Registry Software Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Cancer Registry Software Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across Integrated Software and Standalone Software. The Standalone Software is projected to witness significant market share during forecast period.

Based on Database Type, market is studied across Commercial Databases and Public Databases. The Public Databases is projected to witness significant market share during forecast period.

Based on Functionality, market is studied across Cancer Reporting, Medical Research & Clinical Studies, Patient Care Management, and Product Outcome Evaluation. The Patient Care Management is projected to witness significant market share during forecast period.

Based on Deployment, market is studied across On-Cloud and On-Premise. The On-Cloud is projected to witness significant market share during forecast period.

Based on End User, market is studied across Government Organizations & Third-Party Administrators, Hospitals & Medical Practices, Pharmaceutical, Biotechnology & Medical Device Companies, Private Payers, and Research Centers. The Research Centers is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Cancer Registry Software Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Cancer Registry Software Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cancer Registry Software Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cancer Registry Software Market?

4. What is the competitive strategic window for opportunities in the Global Cancer Registry Software Market?

5. What are the technology trends and regulatory frameworks in the Global Cancer Registry Software Market?

6. What is the market share of the leading vendors in the Global Cancer Registry Software Market?

7. What modes and strategic moves are considered suitable for entering the Global Cancer Registry Software Market?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Cancer Registry Software Market, by Type, 2022 vs 2030
4.3. Cancer Registry Software Market, by Database Type, 2022 vs 2030
4.4. Cancer Registry Software Market, by Functionality, 2022 vs 2030
4.5. Cancer Registry Software Market, by Deployment, 2022 vs 2030
4.6. Cancer Registry Software Market, by End User, 2022 vs 2030
4.7. Cancer Registry Software Market, by Region, 2022 vs 2030

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Surge in prevalences of cancer across the world
  - 5.1.1.2. Growing adoption of electronic health records
  - 5.1.1.3. Increasing demand for cloud-based cancer patients registry software solutions
- 5.1.2. Restraints
  - 5.1.2.1. Lack of awareness about cancer registry software among end-users
- 5.1.3. Opportunities
  - 5.1.3.1. Surge in the government initiatives for development of cancer registry software
  - 5.1.3.2. Technological developments in the cancer registry software solutions
- 5.1.4. Challenges
  - 5.1.4.1. Concern over security and privacy of data
5.2. Market Trends
5.3. Cumulative Impact of COVID-19
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework
5.9. Client Customization

6. Cancer Registry Software Market, by Type

6.1. Introduction
6.2. Integrated Software
6.3. Standalone Software

7. Cancer Registry Software Market, by Database Type

7.1. Introduction
7.2. Commercial Databases
7.3. Public Databases

8. Cancer Registry Software Market, by Functionality

8.1. Introduction
8.2. Cancer Reporting
8.3. Medical Research & Clinical Studies
8.4. Patient Care Management
8.5. Product Outcome Evaluation

9. Cancer Registry Software Market, by Deployment

9.1. Introduction
9.2. On-Cloud
9.3. On-Premise

10. Cancer Registry Software Market, by End User

10.1. Introduction
10.2. Government Organizations & Third-Party Administrators
10.3. Hospitals & Medical Practices
10.4. Pharmaceutical, Biotechnology & Medical Device Companies
10.5. Private Payers
10.6. Research Centers

11. Americas Cancer Registry Software Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Cancer Registry Software Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Cancer Registry Software Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

がん登録ソフトウェア市場：タイプ別、データベースタイプ別、機能別、展開別、エンドユーザー別-2023-2030年の世界予測

Cancer Registry Software Market by Type, Database Type, Functionality, Deployment, End User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

FPNVポジショニング・マトリックス

市場シェア分析

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

第6章 がん登録ソフトウェア市場：タイプ別

第7章 がん登録ソフトウェア市場データベースの種類別

第8章 がん登録ソフトウェア市場機能別

第9章 がん登録ソフトウェア市場：展開別

第10章 がん登録ソフトウェア市場：エンドユーザー別

第11章 南北アメリカのがん登録ソフトウェア市場

第12章 アジア太平洋地域のがん登録ソフトウェア市場

第13章 欧州・中東・アフリカのがん登録ソフトウェア市場

第14章 競合情勢

第15章 掲載企業一覧

第16章 付録